Inventor · disambiguated record
Qihui Jin
Also filed as: JIN QIHUI
8 granted patents·5 pending applications·53 citations·filing 2007–2024
81Inventor score
Top patents by PatentIndex Score
13 records- 0191US8354526B2Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitorsIRM LLC·Filed 2009·Granted Jan 15, 2013·39 cites·23 claims
- 0280US7928133B2Compounds and compositions as hedgehog signaling pathway modulatorsIRM LLC·Filed 2007·Granted Apr 19, 2011·5 cites·6 claims
- 0379US12168646B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Dec 17, 2024·0 cites·21 claims
- 0479US8546370B2Compounds and compositions as kinase inhibitorsOKRAM BARUN·Filed 2009·Granted Oct 1, 2013·9 cites·25 claims
- 0578US12371408B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·20 claims
- 0669US2024398776A1Inhibitors of tgf-beta r1 (alk5) useful to treat cell proliferation disordersNEXYS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0765US2023190751A16-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0852US12102626B2(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancerNEXYS THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2024·0 cites·19 claims
- 0952US11458138B26-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsNOVARTIS AG·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 1052US2023348852A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1145US2020131474A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1234USD1078213SSafe boxJIN QIHUI·Filed 2023·Granted Jun 3, 2025·0 cites·1 claims
- 1334US2011053897A1Compounds and compositions as syk kinase inhibitorsIRM LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qihui Jin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →